Neltenexine

{{Short description|Chemical compound}}

{{Drugbox

| Watchedfields = changed

| verifiedrevid = 444135566

| IUPAC_name = N-(2,4-dibromo-6-{[(4-hydroxycyclohexyl)amino]methyl}phenyl)thiophene-2-carboxamide

| image = Neltenexine.png

| tradename = Alveoten

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 99453-84-6

| ATC_prefix = R05

| ATC_suffix = CB14

| PubChem = 3047787

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 16736685

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = U942DGM90X

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D07382

| C=18 | H=20 | Br=2 | N=2 | O=2 | S=1

| smiles = O=C(Nc2c(CN[C@@H]1CC[C@@H](O)CC1)cc(Br)cc2Br)c3cccs3

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C18H20Br2N2O2S/c19-12-8-11(10-21-13-3-5-14(23)6-4-13)17(15(20)9-12)22-18(24)16-2-1-7-25-16/h1-2,7-9,13-14,21,23H,3-6,10H2,(H,22,24)/t13-,14-

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = SSLHKNBKUBAHJY-HDJSIYSDSA-N

}}

Neltenexine (trade name Alveoten) is a mucolytic.{{cite journal | vauthors = Fadda G | title = Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol | journal = Minerva Medica | volume = 92 | issue = 4 | pages = 269–75 | date = August 2001 | pmid = 11535970 }}